Perspectives in Diagnosis and Treatment of Rabies Viral Encephalitis: Insights from Pathogenesis

Neurotherapeutics

Volumn 13, Issue 3, 2016, Pages 477-492

  Mahadevan, Anita ^a   Suja, M S ^a   Mani, Reeta S ^a   Shankar, Susarala K ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Apoptosis; Negri bodies; Neurovirulence; Pathogenesis; Rabies; Survival

Indexed keywords

ANTIVIRUS AGENT; RABIES VACCINE;

ACTIVE IMMUNIZATION; ANTIVIRAL THERAPY; AUTOPSY; BAT; BODY FLUID; BRAIN BIOPSY; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CORNEAL SMEAR; EYE EXAMINATION; FATALITY; HUMAN; INCUBATION TIME; INFECTION PREVENTION; LOCAL THERAPY; NEUROPATHOLOGY; NONHUMAN; PARALYSIS; PASSIVE IMMUNIZATION; POST EXPOSURE PROPHYLAXIS; PRE-EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; PROGNOSIS; RABIES; RABIES VIRUS; REVIEW; SALIVA; SERODIAGNOSIS; SKIN BIOPSY; SMEAR; SURVIVAL; TREATMENT INDICATION; VACCINATION; VIRUS ENCEPHALITIS; VIRUS ENTRY; VIRUS PATHOGENESIS; VIRUS TRANSMISSION; VIRUS VIRULENCE; WOUND CARE; ANIMAL; COMPLICATION; ENCEPHALITIS, VIRAL; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ENCEPHALITIS, VIRAL; HUMANS; POST-EXPOSURE PROPHYLAXIS; PRE-EXPOSURE PROPHYLAXIS; RABIES; RABIES VIRUS;

EID: 84975257958     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-016-0452-4     Document Type: Review

References (177)

1. Jackson AC. Human disease. In: Jackson AC, Wunner WH, eds. Rabies. San Diego: Academic Press, 2007:309-333
2. Lanska DJ. Rabies virus, paralytic and classical. Lancet 1992; 339:809.
3. MMWR. Investigation of rabies infection in organ donor and transplant recipients – Alabama, Arkansas, Oklahoma, and Texas. MMWR Morb Mort Wkly Rep 2004;53:586-589.
4. Hemachudha T, Laothamatas J, Rupprecht CE. Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet Neurol 2002;1:101-109.
5. World Health Organization. WHO Expert consultation on rabies 2005.Technical report series 931 WHO Geneva 2005.
6. Meslin FX. Report on the status of rabies in the world 3rd international conference on rabies control in Asia 1996.
7. Sudarshan MK, Madhusudana SN, Mahendra BJ, et al. Int J Infect Dis 2007;11:29-35.
8. Gamaleia N. Etude sur la rage paralytique chez L’homme. Ann Inst Pasteur (Paris) 1887;1:63-83.
9. Pawan J. Paralysis as a clinical manifestation in human rabies. Ann Trop Med Parasitol 1939;33:21-29.
10. Banerjee AK, Chopra JS. Paralytic rabies. Neurol India 1974; 22:83-86.
11. Chopra JS, Banerjee AK, Murthy JMK, Pal SR. Paralytic rabies. A clinico-pathological study. Brain 1980;103:789-802.
12. Jackson AC. Update on rabies. Curr Opin Neurol 2002;15:327-331.
13. Jackson AC. Rabies virus infection: an update. J Neurovirol 2003;9:253-258.
14. Hemachudha T, Wacharapluesadee S, Mitrabhakdi E, Wilde H. Pathophysiology of human paralytic rabies. Mini-review—the rabies virus. J Neurovirol 2005;11:93-100.
15. Fishbein D, Robinson L. Current concepts: rabies. N Engl J Med 1993;329:1632.
16. Messenger SL., Smits JS., Rupprecht CE. Emerging epidemiology of bat-associated cryptic cases of rabies in humans in the United States. Clin Infect Dis, 2002; 35: 738-747.
17. Winkler WG., Fashinell TR., Leffingwell L., Howard P., Conomy JP. Airborne rabies transmission in a laboratory worker. J Am Med Assoc 1973; 226: 1219-1221.
18. Gibbons RV. Cryptogenic rabies, bats, and the question of aerosol transmission. Ann Emerg Med 2002, 39, 528-536.
19. Houff SA, Burton RC, Wilson RW, et al. Human-to-human transmission of rabies virus by corneal transplant. N Engl J Med 1979;300:603-604.
20. Vetter JM, Frisch L, Drosten C, et al. Survival after transplantation of corneas from a rabies-infected donor. Cornea 2011;30:241-244.
21. Srinivasan A, Burton EC, Kuehnert MJ, et al.; Rabies in Transplant Recipients Investigation Team. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005;352:1103-1111
22. Maier T, Schwarting A, Mauer D, et al. Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. Clin Infect Dis 2010;50(8):1112-1119.
23. Vora NM, Basavaraju SV, Feldman KA, et al.; Transplant-Associated Rabies Virus Transmission Investigation Team. Raccoon rabies virus variant transmission through solid organ transplantation. JAMA 2013;310:398-407.
24. Dutta JK. Rabies transmission by oral and other non-bite routes. J Indian Med Assoc 1998;96:359.
25. Hemachudha T. Rabies. In: PJ Vinken, GW Bruyn, HL Klawans, eds. Handbook of Clinical Neurology. Revised series, Amsterdam: Elsevier Science Publishers 1989:383-404.
26. Smith JS, Fishbein D, Rupprecht CE, et al. Unexplained rabies in three immigrants in the United States: a virologic investigation. N Eng J Med 1991;324:205-211.
27. Shankar SK, Mahadevan A, Sapico SD, Ghodkirekar MS, Pinto RG, Madhusudana SN. Rabies viral encephalitis with proable 25 year incubation period! Ann Indian Acad Neurol 2012;15:221-223.
28. Charlton KM, Nadin-Davis S, Casey GA, Wandeler AI. The long incubation period in rabies: delayed progression of infection in muscle at site of exposure. Acta Neuropathol 1997;94:73-77.
29. Charlton KM, Casey GA. Experimental rabies in skunks: immunofluorescent and electron microscopic studies. Lab Invest 1979;41:36-44.
30. Charlton KM, Casey GA. Experimental rabies in skunks: persistence of virus in denervated muscle inoculation site. Can J Comp Med 1981;45:357-362.
31. Lentz TL, Burrage TG, Amith AL, Crick J, Tignor GH. Is the acetylcholine receptor a rabies virus receptor? Science 1982; 215:182-184.
32. Thoulouze MI, Lafage M, Schachner M, Hartmann U, Cremer H, Lafon M. The neural cell adhesion molecule is a receptor for rabies virus. J Virol 1998;72:7181-7190.
33. Moscoso LM, Cremer H, Sanes JR. Organization and reorganization of neuromuscular junctions in mice lacking neural cell adhesion molecule, tenascin-C, or fibroblast growth factor-5. J Neurosci 1998;18:1465-1477.
34. Polo-Parada L, Bose CM, Landmesser LT. Alterations in transmission, vesicle dynamics, and transmitter release machinery at NCAM-deficient neuromuscular junctions. Neuron 2001;32:815-828.
35. Tuffereau C, Banejean J, Blondel D, Kieffer B, Flamand A. Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus. EMBO J 1998;17:7250-7259.
36. Baer GM, Bellini WJ, Fishbein DB. Rhabdoviruses. In: BN Fields and DM Knipe, eds. Virology. New York: Academic Press 1990:883-930.
37. Baer GM, Shaddock JH, Quirion R, et al. Rabies susceptibility and acetylcholine receptor. Lancet 1990;335:664-665.
38. Langevin C, Jaaro H, Bressanelli S, Fainziber M, Tuffereau C. Rabies virus glycoprotein (RVG) is a trimeric ligand for the N-terminal cysteine-rich domain of the mammalian p75 neurotrophin receptor. J Biol Chem 2002;277:37655.
39. Superti F, Hauttecoeur B, Morelec MJ, Goldoni P, Bizzini B, Tsiang H. Involvement of gangliosides in rabies virus infection. J Gen Virol 1986;67:47-56.
40. Conti C, Superti F, Siang F. Membrane carbohydrate requirement for rabies virus binding to chicken embryo related cells. Intervirology 1986; 26:164-168.
41. Tang Y, Rampin O, Guiliano F, Ugolini G. Spinal and brain circuits to motorneurons of the bulbospongiosus muscle: retrograde transneuronal tracing with rabies virus. J Comp Neurol 1999;414:167-192.
42. Kelly RM, Strick PL. Rabies as a transneuronal tracer of circuits in the central nervous system. J Neurosci Methods 2000;103:63-71
43. Steele JH, Fernandez PJ. History of rabies and Global Aspects. In: Baer GM (Ed), The Natural History of Rabies (2nd Edition),1991; pp1.
44. Kucera P, Dolivo M, Coulon P, Flamand A. Pathways of early propogation of virulent and avirulent rabies strains from eye to the brain. J Virol 1985; 55:158-162.
45. Tsiang H, Ceccaldi PE, Lycke E. Rabies virus infection and transport in human sensory dorsal root ganglia neurons. J Gen Virol 1991;72:1191-1194.
46. Lycke E, Tsiang H. Rabies virus infection of cocultured rat sensory neuron. J Virol 1987;61:2733-2741.
47. Tsiang H. Evidence for intraaxonal transport of fixed and street rabies virus. J Neuropathol Exp Neurol 1979;38:286-297.
48. Ceccaldi PE, Gillet JP, Tsiang H. Inhibition of the transport of rabies virus in the central nervous system. J Neuropathol Exp Neurol 1989;48:620-630.
49. Ceccaldi PE, Ermine A, Tsiang H. Continuous delivery of colchicine in the rat brain with osmotic pumps for inhibition of rabies virus transport. J Virol Methods 1990;28:79-83.
50. Tsiang H. Pathophysiology of rabies virus infection of the nervous system. Adv Virus Res 1993;42:375-412.
51. Van Harreveld A, Crowell H, Malhotra SK. A study of extracellular space in central nervous tissue by freeze-substitution. J Cell Biol 1965;25:117-137.
52. Charlton KM, Casey GA, Wandeler AI, et al. Early events in rabies virus infection of the central nervous system in skunks (Mephitis mephitis). Acta Neuropathol 1996;91:89-98.
53. Baer GM, Shanthaveerappa TR, Bourne GH. The pathogenesis of street virus rabies in rats. Bull WHO 1968;38:119-125.
54. Bylenga G, Haeney T. Post exposure local treatment of mice infected with rabies with two axonal inhibitors colchicines and vinblastine. J Gen Virol 1978;50:433-435.
55. Prevosto V, Graf W, Ugolini G. Cerebellar inputs to intraparietal cortex areas LIP and MIP: functional frameworks for adaptive control of eye movements, reaching, and arm/eye/head movement coordination. Cerebral Cortex (New York, NY). 2010;20:214-228.
56. Ugolini G. Specificity of rabies virus as a transneuronal tracer of motor networks: transfer from hypoglossal motor neurons to connected second-order and higher order central nervous system cell groups. J Comp Neurol 1995;365:457-480.
57. Hirokawa N, Takemura R. Molecular motors and mechanisms of directional transport in neurons Nat Rev Neurosci 2005;6:201-214
58. Bauer A, Nolden T, Schröter J, et al. Anterograde glycoprotein-dependent transport of newly generated rabies virus in dorsal root ganglion neurons. J Virol 2014;88:14172-14183.
59. Iwasaki Y, Clark HF. Cell to cell transmission of virus in the central nervous system II. Experimental rabies in the mouse. Lab Invest 1975;33:391-399.
60. Iwasaki Y, Liu DS, Yamamoto T, Konno H. On the replication and spread of rabies virus in the human central nervous system. J Neuropathol Exp Neurol 1985;44:185-195.
61. Dean DJ, Evans WM, McClure RC. Pathogenesis of rabies. Bull WHO 1963;29:803-811.
62. Ugolini G. Rabies virus as a transneuronal tracer of neuronal connections. Adv Virus Res 2011;79:165-202
63. Jackson AC, Ye H, Phelan CC, et al. Extraneural organ involvement in human rabies. Lab Invest 1999;79:945-951
64. Jogai S, Radotra BD, Banerjee AK. Rabies viral antigen in extracranial organs: a post-mortem study. Neuropathol Appl Neurobiol 2002;28:334-338.
65. Etessami R, Conzelmann KK, Fadai-Ghotbi B, Netelson B, Tsiang H, Ceccaldi PE. Spread and pathogenic characteristics of a G-deficient rabies virus recombinant: an in vitro and in vivo study. J Gen Virol 2000;81:2147-2153.
66. Yan X, Mohankumar PS, Dietzschold B, Schnell M, Fu ZF. The rabies virus glycoprotein determine the distribution of different rabies virus strains in the brain. J Neurovirol 2002;8:345-352.
67. Mazarakis ND, Azzouz M, Rohll JB, et al. Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the central nervous system after peripheral delivery. Hum Mol Genet 2001;10:2109-2121.
68. Wunner WH. Rabies virus. In: Jackson AC, Wunner WH, eds. Rabies. New York: Academic Press 2002:23-77.
69. Poisson N, Real E, Gaudin Y, et al. Molecular basis for the interaction between rabies virus phosphoprotein P and the dynein light chain LC8: dissociation of dynein-properties and transcriptional functionality of P. J Gen Virol 2001;82:2691-2696.
70. Jacob Y, Badrane H, Ceccaldi PE, Tordo N. Cytoplasmic dynein LC8 interacts with lyssavirus phosphoprotein. J Virol 2000;74:10217-10222.
71. Raux H, Flamand A, Blondel D. Interaction of the rabies virus P protein with the LC8 dynein light chain. J Virol 2000;74:10212-10216.
72. Mebatsion T. Extensive attenuation of rabies virus by simultaneously modifying the dynein light chain binding site in the P protein and replacing Arg333 in the G protein. J Virol 2001;75:11496-11502.
73. Hernáez B(1), Tarragó T, Giralt E, Escribano JM, Alonso C. Small peptide inhibitors disrupt a high-affinity interaction between cytoplasmic dynein and a viral cargo protein. J Virol 2010;84:10792-10801.
74. Moseley GW, Lahaye X, Roth DM, et al. Dual modes of rabies P-protein association with microtubules: a novel strategy to suppress the antiviral response. J Cell Sci 2009;122:3652-3662
75. Hirosue S, Senn K, Clément N, et al. Effect of inhibition of dynein function and microtubule-altering drugs on AAV2 transduction. Virology 2007;367:10-18.
76. Hemachudha T. Human rabies: clinical aspects, pathogenesis and potential therapy. In: CE Rupprecht, B Dietzschold, H Koprowski, eds. Lyssaviruses. New York: Springer-Verlag, Berlin, Germany 1994;187; 121-144.
77. Laothamatas J, Hemachudha T, Mitrabhakdi E, Wannakrairot P, Tulayadaechanont S. MR imaging in human rabies. AJNR Am J Neuroradiol 2003;24:1102-1109.
78. Mitrabhakdi E, Shuangshoti S, Wannakrairot P, et al. Difference in neuropathogenetic mechanisms in human furious and paralytic rabies. J Neurol Sci 2005; 238:3-10.
79. Hemachudha T, Panpanich T, Phanuphak P, Manutsathit S, Wilde H. Immune activation in human rabies. Trans R Soc Trop Med Hyg 1993; 87:106-108.
80. Sriwanthana B, Hemachuda T, Griffin DE, Manustsathit S, Tweardy D, Phanuphak P. Lymphocyte subsets in human encephalitic and paralytic rabies. Acta Neurol Scand 1989;80:287-289.
81. Hemachudha T, Phanuphak P, Sriwanthana B, et al. Immunologic study of human encephalitic and paralytic rabies. Preliminary report of 16 patients. Am J Med 1988;84:673-677.
82. Tangchai P, Vejjajiva A. pathology of the peripheral nervous system in human rabies:a study of nine cases. Brain 1971;94:299-306.
83. Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies. J Infect Dis 2003;188:960-966.
84. Gadre G, Satishchandra P, Mahadevan A, et al. Rabies viral encephalitis: clinical determinants in diagnosis with special reference to paralytic form. J Neurol Neurosurg Psychiatry 2010;81:812-820.
85. Mahadevan A, Suja MS, Madhusudana SN, Patil S, Satishchandra P. Guillain Barré syndrome versus paralytic rabies – at the spinal level. 2nd International Conference of Rabies in Asia (RIA) Foundation. Sept 2009 [Abstract].
86. Ogawara K, Kuwabara S, Mori M, Hattori T, koga M, Yuki N. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 2000;48:624-631.
87. Sheikh KA, Ramos-Alvarez M, Jackson AC, Li CY, Asbury AK, Griffin JW. Overlap of pathology in paralytic rabies and axonal Guillain-Barre syndrome. Ann Neurol 2005;57:768-772.
88. Gorson KC, Rooper A, Muriello M, Blair R. Prospective evaluation of MRI lumbosacral nerve root enhancement in acute Guillain-Barré syndrome. Neurology 1996;47:813-817.
89. Hemachudha T, Mitrabhakdi E. Rabies. In: Davis L, Kennedy PGE, eds. Infectious diseases of the nervous system. Oxford: Butterworth-Heinemann 2000:404-444.
90. Goswami U, Shankar SK, Channabasavanna SM, Chattopadhyay A. Psychiatric presentations in rabies. A clinico-pathologic report from South India with a review of literature. Trop Geogr Med 1984;36:77-81.
91. Smart NL, Charlton KM. The distribution of challenge virus standard rabies virus versus skunk street rabies virus in the brains of experimentally infected skunks. Acta Neuropathol 1992;84:501-508.
92. Madhusudana SN. Rabies presenting with sexual manifestations. J Indian Med Assoc 1988;86:43-44
93. Suja MS, Mahadevan A, Madhusudana SN, Shankar SK. Is death in rabies related to specific neuroanatomical pathology?—A study in human, canine and rodent brains. 2nd International Conference of Rabies in Asia (RIA) Foundation. Sept 2009 [Abstract].
94. Perl DP, Good PF. The pathology of rabies in the central nervous system. In: GM Baer (ed). 2nd edn, The Natural History of Rabies. CRC Press: Boca Raton, FL 1991:163-190.
95. Iwasaki Y, Tobita M. Pathology. In: Jackson AC, Wunner WH, eds. Rabies. Academic Press: San Diego, CA 2002:283-306.
96. Fu ZF, Jackson AC. Neuronal dysfunction and death in rabies virus infection. J Neurvirol 2005;11:101-106
97. Iwata M, Komori S, Unno T, Minamoto N, Ohashi H. Modification of membrane currents in mouse neuroblastoma cells following infection with rabies virus. Br J Pharmacol 1999;126:1691-1698.
98. Tsiang H. Neuronal function impairment in rabies infected rat brain. J Gen Virol 1982;61:277-281.
99. Koprowski H, Zheng YM, Heber-Katz E, et al. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic disease. Proc Natl Acad Sci U S A 1993;90: 3024-3027.
100. Hooper DC, Ohnishi ST, Kean R, Numagami Y, Dietzschold B, Koprowski H. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc Natl Acad Sci U S A 1995; 92:5312-5316.
101. Griffin DE, Hardwick JM. Perspective: Virus infections and the death of neurons. Trends Microbiol 1999;7:155-160.
102. Fazakerley JK, Allsopp TE. Programmed cell death in virus infections of the nervous system. Curr Top Microbiol Immunol 2001; 253:95-119.
103. Murphy FA. Rabies pathogenesis. Arch Virol 1977; 54:279-297.
104. Jackson AC, Park H. Apoptotic cell death in experimental rabies in suckling mice. Acta Neuropathol 1998;95:159-164.
105. Morimoto K, Hooper DC, Spitsin S, Koprowski H, Dietzschold B. Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein in infected primary neuron cultures. J Virol 1999;73:510-518.
106. Reid JE, Jackson AC. Experimental rabies virus infection in Artibeus jamaicensis bats with CVS-24 variants. J Neurovirol 2001; 7: 511-517.
107. Park Chun-Ho, Kondo M, Inoue S, et al. The Histopathogenesis of paralytic rabies in six week old C57BL/6J mice following inoculation following inoculation of the CVS-11 strain into the right triceps surae muscle. J Vet Med Sci 2006;68:589-595.
108. Theerasurakarn S, Ubol S. Apoptosis induction in brain during the fixed strain of rabies virus infection correlates with onset and severity of illness. J Neurovirol 1998;4:407-414
109. Jackson AC, Rasalingam P, Weli SC. Comparative pathogenesis of recombinant rabies vaccine strain SAD-L16 and SAD-D29 with replacement of Arg333 in the glycoprotein after peripheral inoculation of neonatal mice: less neurovirulent strain is a stronger inducer of neuronal apoptosis. Acta Neuropathol 2006;111:372-378.
110. Ubol S, Kasisith J. Reactivation of Nedd-2, a developmentally down-regulated apoptotic gene, in apoptosis induced by a street strain of rabies virus. J Med Microbiol 2000;49:1043-1046.
111. Yan X, Mohankumar PS, Dietzschold B, Schnell MJ, Fu ZF. The rabies virus glycoprotein determines the distribution of different rabies virus strains in the brain. J Neurovirol 2001;8:345-352.
112. Jackson AC, Randle E, Lawrance G, Rossiter JP. Neuronal apoptosis does not play an important role in human rabies encephalitis. J Neurovirol 2008;14:368-375.
113. Suja MS, Mahadevan A, Madhusudana SN, Shankar SK. Role of apoptosis in rabies viral encephalitis: a comparative study in mice, canine, and human brain with a review of literature. Patholog Res In. 2011;2011:374286.
114. Scott CA, Rossiter JP, Andrew RD, Jackson AC. Structural abnormalities in neurons are sufficient to explain the clinical disease and fatal outcome of experimental rabies in yellow fluorescent protein-expressing transgenic mice. J Virol 2008; 82:513-521.
115. Kammouni W, Wood H, Saleh A, Appolinario CM, Fernyhough P, Jackson AC. Rabies virus phosphoprotein interacts with mitochondrial Complex I and induces mitochondrial dysfunction and oxidative stress. J Neurovirol 2015;21:370-382.
116. Dacheux L, Reynes JM, Buchy P, et al. A reliable diagnosis of human rabies based on analysis of skin biopsy samples. Clin Infect Dis 2008:47:1410–1417.
117. Hemachudha T., Wacharapluersadee S. Antemortem diagnosis of human rabies. Clin Infect Dis 2004;39:1085-1086.
118. Madhusudana SN, Sukumaran SM. Antemortem diagnosis and prevention of human rabies. Ann Ind Acad Neurol 2008;11:3-12.
119. Antemortem testing. Rabies. http://www.cdc.gov/rabies/specific_groups/doctors/ante_mortem.html
120. World Health Organization. Expert Consultation on Rabies. 1. Report. Geneva: WHO Tech. Rep. Series 931, 2004.
121. Hooper DC., Morimoto K., Bette M., Weihe M., Koprowski H., Dietshchold B. Collaboration of antibody and inflammation in the clearance of rabies virus from the CNS. J Virol 1998;72:3711-3719.
122. Crepin P, Audry L, Rotivel Y, Gacoin A, Caroff C, Bourhy H. Intravitam diagnosis of human rabies by PCR using saliva and cerebrospinal fluid. J Clin Microbiol 1998;36:1117-1121
123. Macedo CI, Carnieli PJ, Brandao PE, et al. Diagnosis of human rabies cases by polymerase chain reaction of neck-skin samples. Braz J Infect Dis 2006;10:341-345.
124. Koch KJ., Sagartz JW., Davidson D., Lawhaswahs K. Diagnosis of human rabies by cornea test. Am J Clin Pathol 1975;63:509-515.
125. Wacharapluesadee S, Hemachudha T. Ante mortem postmortem diagnosis of rabies using nucleic acid amplification tests. Expert Rev Mol Diagn 2010;10:207-218.
126. Mani RS, Madhusudana SN. Laboratory diagnosis of human rabies: recent advances. ScientificWorldJournal 2013;2013:569712
127. Mani RS, Madhusudana SN, Mahadevan A, Reddy V, Belludi AY, Shankar SK. Utility of real-time Taqman PCR for antemortem and postmortem diagnosis of human rabies. J Med Virol 2014;86:1804-1812.
128. Mani RS, Anand AM, Madhusudana SN. Human rabies in India: an audit from a rabies diagnostic laboratory. Trop Med Int Health 2016;21:556-563.
129. Montano Hirose JA, Bourhy H, Sureau P. Retro-orbital route for brain specimen collection for rabies diagnosis. Vet Rec 1991;129:291-292.
130. Tong TR, Leung KM, Lee KC, Lam AW. Trucut needle biopsy through superior orbital fissure for the diagnosis of rabies. Lancet 1999;354:2137-2138.
131. Sudarsanam TD, Chacko G, David RD. Postmortem trucut transnasal brain biopsy in the diagnosis of encephalitis. Trop Doct 2008;38:163-165.
132. Sow PS, Diop BM, Ndour CT, et al. La ponction aspiration sous-occipitale: technique de prélèvement cérébral post-mortem pour le diagnostic virologique de l encéphalite rabique humaine à Dakar. Med Mal Infect 1996;26:534-536.
133. Neizgoda M, Rupprecht CE. Standard operating procedure for the direct rapid immunohistochemistry test for the detection of rabies virus antigen. Atlanta, GA: National Laboratory Training Network Course; US Department of Health and Human Services; Centers for Disease Control and Prevention; 2006
134. Binghem J., Van Der Merwe M. Distribution of rabies antigen in infected material: determining the reliability of different regions of the brain for the rabies fluorescent antibody test. J Virol Methods 2002;101:85-94.
135. Venugopal AK, Ghantasala SS, Selvan LD, et al. Quantitative proteomics for identifying biomarkers for Rabies. Clin Proteomics. 2013;10:3.
136. O'Sullivan A, Willoughby RE, Mishchuk D, et al. Metabolomics of cerebrospinal fluid from humans treated for rabies. J Proteome Res 2013;12:481-490.
137. Centers for Disease Control and Prevention. Human rabies prevention—United States, 1999: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1999;48(RR-1):1-21.
138. Dean D, Baer G, Thowpson W. Studies on the local treatment of rabies infected wounds. Bull World Health Organ 1963;28:477.
139. World Health Organization. Guidelines for post exposure treatment. 8th Report of the WHO Expert Committee on Rabies. Geneva: WHO, 2000.
140. Jackson AC, Warrell MJ, Rupprecht CE, et al. Management of rabies in humans. Clin Infect Dis 2003;36:60-63.
141. Willoughby RE, Rotar MM, Dohnau HL, et al. Recovery of a patient from clinical rabies—Wisconsin, 2004. MMWR Morb Mortal Wkly Rep 2005;53:1171-1173.
142. Hunter M, Johnson N, Hedderwick S, et al. Immunovirological correlates in human rabies treated with therapeutic coma. J Med Virol 2010;82:1255–1265.
143. Pue HL, Turabelidze G, Patrick S, et al. Human Rabies. Missouri, 2008. MMWR Morb Mortal Wkly Rep 2009;58:1207–1209.
144. Hemachudha T, Sunsaneewitayakul B, Desudchit T. Failure of therapeutic coma and ketamine for therapy of human rabies. J Neurovirol 2006;12:407–409.
145. McDermid RC, Saxinger L, Lee B. Human rabies encephalitis following bat exposure: failure of therapeutic coma. Can Med Assoc J 2008;178:557–561.
146. Jackson AC. Update on rabies diagnosis and treatment. Curr Infect Dis Rep 2009;11:296–301.
147. Jackson AC. Therapy of human rabies. In: Jackson AC (ed.), Rabies-Scientific Basis of Disease and its Management (3rd edn). Academic Press: Oxford, 2013; 575–585.
148. Dietzschold B, Kao M, Zheng YM, et al. Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system. Proc Natl Acad Sci U S A 1992;89:7252-7256.
149. Lockhart BP, Tordo N, Tsiang H. Inhibition of rabies virus transcription in rat cortical neurons with the dissociative anesthetic ketamine. Antimicrob Agents Chemother 1992; 36:1750–1755.
150. Tam RC., Lau JY., Hong Z. Mechanisms of action of ribavirin in antiviral therapies. Antivirol Chem Chemother 2001;12:261-272.
151. Bussereau F, Ermine A. Effects of heteropolyanions and nucleoside analogues on rabies virus: in vitro study of syntheses and viral production. Ann Virol (Inst Pasteur) 1983;134E:487-506.
152. Bussereau F, Picard M, Blancou J, Sureau P. Treatment of rabies in mice and foxes with antiviral compounds. Acta Virol 1988;32:33-49.
153. Warrell MJ, White NJ, Looareesuwan S, et al. Failure of interferon alfa and tribavirin in rabies encephalitis. BMJ 1989;299:830-833.
154. Enright JB, Franti CE, Frye FL, Behymer D. The effects of corticosteroids on rabies in mice. Can J Microbiol 1970;16:667-675.
155. Basgoz N., Frosch MP. Case 21-1998. A 32-year-old woman with pharyngeal spasms and paresthesias after a dog bite. N Engl J Med 1998;339:105-112.
156. Dietzschold B, Morimoto K, Hooper DC, Smith JS, Rupprechet CE, Koprowski H. Genotypic and phenotypic diversity of rabies virus variants involved in human rabies: implications for postexposure prophylaxis. J Hum Virol 2000;3:50-57.
157. CDC. Rabies in a laboratory worker—New York. MMWR 1977;26:183-184.
158. Hattwick MA, Weis TT, Stechschulte CJ, Baer GM, Gregg MB. Recovery from rabies. A case report. Ann Intern Med 1972;76:931-942.
159. Porras C, Barboza JJ, Fuenzalida E, Adaros HL, Oviedo AM, Furst J. Recovery from rabies in man. Ann Intern Med 1976;85:44-48.
160. Alvarez L, Fajardo R, Lopez E, et al. Partial recovery from rabies in a nine-year-old boy. Pediatr Infect Dis J 1994;13:1154-1155.
161. Madhusudana SN, Nagaraj D, Uday M, Ratnavalli E, Kumar MV. Partial recovery from rabies in a six-year-old girl. Int J Infect Dis 2002;6:85-86.
162. de Souza A, Madhusudana SN. Survival from rabies encephalitis. J Neurol Sci 2014;339:8-14.
163. Karande S, Muranjan M, Mani RS, et al. Atypical rabies encephalitis in a six-year-old boy: clinical, radiological, and laboratory findings. Int J Infect Dis 2015;36:1-3.
164. Netra, et al. Unique clinical and imaging findings in a first ever documented PCR positive rabies survival patient: a case report. J Clin Virol 2015;70:83-88.
165. Kumar KV, Ahmad FM, Dutta V. Pituitary cachexia after rabies encephalitis. Neurol India 2015;63:255-256.
166. Emmons RW, Leonard LL, DeGenaro F, et al. A case of human rabies with prolonged survival. Intervirology 1973;1:60-72.
167. Gode GR, Raju AV, Jayalakshmi TS, Kaul HL, Bhide NK. Intensive care in rabies therapy: clinical observations. Lancet 1976;2:6-8.
168. Sandhyamani S, Roy S, Gode GR, Kalla GN. Pathology of rabies: a light and electron microscopic study with particular reference to changes in cases with prolonged survival. Acta Neuropathol 1981;54:247-251.
169. Mejid J, Appolinario CM, Mazzini AM, Almeida MF. Evaluation of cytokines concentration and percentage of survival of rabies virus-infected mice submitted to anti-rabies Vero-cell propagated vaccine and P. acnes. Vet Immunol Immunopathol 2006;114:192-196.
170. Ubol S, Sukwattanapan C, Maneerat Y. Inducible nitric oxide synthase delays death of rabies virus. J Med Microbiol 2001;50:238-242.
171. Camelo S, Lafage M, Lafon M. Absence of the p55 Kd TNF-α receptor promotes survival in rabies virus acute encephalitis. J Neurovirology 2000;6:507-518.
172. Lafon M. Immunology. In: Jackson AC, Wunner WH, editors. Rabies. San Diego, CA: Academic Press; 2002. p. 351-369.
173. World Health Organization, WHO Expert Consultation on Rabies. Second report, World Health Organization Technical Report Series 982, 2013.
174. Strady C, Hung Nguyen V, Jaussaud R, et al. Pre-exposure rabies vaccination: strategies and cost-minimization study. Vaccine 2001;19:1416-1424
175. National Advisory Committee on Immunization. Update on rabies vaccine. Can Commun Dis Rep 2005;1:1-8.
176. Madhusudana SN, Mani RS. Intradermal vaccination for rabies prophylaxis: conceptualization, evolution, present status and future. Expert Rev Vaccines 2014;13:641-655.
177. World Health Organization (WHO). WHO recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies. Geneva: World Health Organization; 1997. WHO/EMC/ZOO/96.6, 1-23. http://www.who.int/emc-documents/rabies/docs/whoemczoo966.pdf. Accessed, November 22, 2002.